Clinical Course and Outcome of COVID-19 Acute Respiratory Distress Syndrome: Data From a National Repository.
Ali Albert El-SolhUmberto G MeduriYolanda LawsonMichael CarterKari A MergenhagenPublished in: Journal of intensive care medicine (2021)
Among those hospitalized for COVID-19, nearly 1 in 10 progressed to ARDS. Septic shock, and acute renal failure are the leading causes of death in these patients. Treatment with either remdesivir and corticosteroids reduced the risk of mortality from ARDS. All hospitalized patients with COVID-19 should be placed at a minimum on prophylactic doses of anticoagulation.
Keyphrases
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation
- mechanical ventilation
- coronavirus disease
- septic shock
- sars cov
- respiratory failure
- end stage renal disease
- ejection fraction
- peritoneal dialysis
- atrial fibrillation
- liver failure
- cardiovascular events
- electronic health record
- risk factors
- quality improvement
- machine learning
- coronary artery disease
- respiratory syndrome coronavirus
- data analysis
- smoking cessation
- replacement therapy